# Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

> **NCT01102413** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 351 (actual)

## Conditions studied

- Iron Deficiency Anemia
- Chronic Kidney Disease

## Interventions

- **DRUG:** Monofer
- **DRUG:** Iron Sulphate

## Key facts

- **NCT ID:** NCT01102413
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102413, "Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01102413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*